-
ICLR IMPORTANT DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ICON plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 11 Deadline in Securities Class Action – ICLR
04 Apr 2025 23:14 GMT
… ROSEN LAW: We encourage investors to select qualified counsel … Rosen Law Firm represents investors throughout the globe, concentrating … over $438 million for investors. In 2020, founding partner … ICON received from its biotechnology customers during the Class …
-
Belgian Consul General: Trade Uncertainty Could Delay Investments
04 Apr 2025 22:18 GMT
… tariff turmoil could eventually delay investments from Belgium, a longstanding … visiting many existing Belgian investors in the region and … excellence in fields like vaccines, biotechnology, petrochemicals, pharmaceuticals, aerospace, artificial …
-
Edesa Biotech Announces Chief Financial Officer Transition
04 Apr 2025 20:21 GMT
… and corporate strategy within the biotechnology and pharmaceutical industries. Since … Dr. Nijhawan.
About
Edesa
Biotech,
Inc.
Edesa Biotech, Inc. (Nasdaq: EDSA) …
Contact:
Gary Koppenjan
Edesa Biotech, Inc.
investors@edesabiotech.com
Article content
Share …
-
Edesa Biotech Announces Chief Financial Officer Transition
04 Apr 2025 20:15 GMT
… and corporate strategy within the biotechnology and pharmaceutical industries. Since August … Dr. Nijhawan. About Edesa Biotech, Inc. Edesa Biotech, Inc. (Nasdaq: EDSA) is … statements. Contact:
Gary Koppenjan
Edesa Biotech, Inc.
investors@edesabiotech.com
-
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Apr 2025 20:05 GMT
… , 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today … covering the grant. About Adverum Biotechnologies Adverum Biotechnologies (NASDAQ: ADVM) is a … www.adverum.com. Inquiries: Adverum Investor Relations Email: ir@adverum.com
-
Once-promising central Ohio biotech firm shuts down
04 Apr 2025 18:57 GMT
… $200 million in venture capital investments. Investors included Battelle, JD Vance… company said the climate for biotech investment has changed since its founding … a scarcity of investor financing for early-stage biotech companies, which greatly …
-
Class Action Filed Against Sana Biotechnology, Inc. (SANA) - May 20, 2025 Deadline to Join – Contact Levi & Korsinsky
04 Apr 2025 17:42 GMT
… ; Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ("Sana Biotechnology, Inc.… losses on behalf of Sana Biotechnology, Inc. investors who were adversely affected …
-
Sheatrust Capital’s Joshua Oduyemi: From Lagos to Silicon Valley’s investment elite
04 Apr 2025 17:00 GMT
… investment firm with notable success in venture capital, private equity, and biotechnology … inclusive capital into breakthrough biotech innovation, using private … healthcare, enterprise software, energy, biotechnology, and pharmaceuticals. His leadership …
-
This Is the Overlooked Industry You Should Start Investing in Now
04 Apr 2025 15:47 GMT
… need for advanced healthtech solutions.
Investment opportunities in healthtech
The healthtech … market has massive investment potential across various sectors.
… of 23% by 2030. Biotechnology continues to attract investors, driven by advancements …
-
Are Trump’s tariffs a once-in-a-lifetime chance for ISA investors to get rich?
04 Apr 2025 15:12 GMT
… advice before making any investment decisions.
Global trade … ISA!
Long-term investing
Unfortunately, investors may have to endure … could freeze companies’ capital investments, and share prices suffer … FTSE 100 stocks like biotech giant AstraZeneca and defence …
About
© 1995-2025